CLNN.NASDAQClene INC

Form 4: Clene Inc. Director David J. Matlin Acquires Shares and Warrants

Sentiment:

SEC Form 4


๐Ÿ“‹All filings for Clene INC

Director David J. Matlin reports acquisition of Clene Inc. shares and warrants, increasing his direct and indirect holdings.

Summary

  • On September 30, 2024, David J. Matlin, a director of Clene Inc., acquired 92,307 shares of common stock at a price of $4.75 per share.
  • The transaction also involved the acquisition of warrants to purchase 92,307 shares of common stock at an exercise price of $4.82.
  • Following the reported transactions, Matlin directly owns 444,491 shares of common stock and indirectly owns 7,500 shares through the Matlin Family Trust 2020.
  • The warrants expire on October 1, 2029.
  • A 1-for-20 reverse stock split occurred on July 11, 2024, which reduced Matlin's previously held shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The director's purchase could be seen as a positive signal, but it's not definitively bullish.

Positives

  • Director's purchase of shares and warrants may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's stock.

Stakeholder Impact

  • Shareholders may view the director's purchase as a positive sign.

Key Dates

DateDescription
July 11, 20241-for-20 reverse stock split
September 30, 2024Acquisition of shares and warrants by David J. Matlin
October 01, 2029Expiration date of warrants
October 02, 2024Date of signature

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.